We generated stable PABPC4-knockdown cell lines via the CRISPR-Cas9 system, and both in vitro and in vivo studies demonstrated that the overexpression of PABPC4 promoted tumor proliferation. The gene discussed is PABPC4; the disease is neoplasm.